| Financial Year |
March 31 2023 |
| Monetary Funds |
7,144,098,988.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
494,256,548.00 |
| Accounts Receivable |
1,939,479,569.00 |
| Advances to Suppliers |
454,195,957.00 |
| Other Receivables |
441,673,942.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,288,269,881.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
778,479,202.00 |
| Total Current Assets |
14,839,428,904.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
131,629,618.00 |
| Long-term Equity Investment |
430,891,159.00 |
| Investment Properties |
-- |
| Fixed Assetes |
24,112,499,897.00 |
| Under-construction Projects |
5,005,314,794.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,871,071,907.00 |
| R&D expenses |
49,037,425.00 |
| Goodwill |
618,543,411.00 |
| Long-Term Deferred and Prepaid Expenses |
792,781,977.00 |
| Deferred Income Tax Assets |
493,275,238.00 |
| Other Non-Current Assets |
1,116,088,406.00 |
| Sub-Total of Non-Current Assets |
49,902,194,087.00 |
| Total Assets |
64,741,622,991.00 |
| Short-Term Loans |
789,769,924.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
921,193,834.00 |
| Accounts Payable |
7,219,751,069.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
140,268,116.00 |
| Taxes Payable |
557,874,172.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,079,736,831.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,300,629,709.00 |
| Other Current Liabilities |
88,609,421.00 |
| Sub-Total of Current Liabilities |
15,922,378,683.00 |
| Long-term Loans |
8,301,732,828.00 |
| Bonds Payable |
4,397,868,259.00 |
| Long-Term Accounts Payable |
2,843,562,287.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
428,039,639.00 |
| Deferred Income Tax Liabilities |
600,379,797.00 |
| Other Non-Current Liabilities |
104,940,000.00 |
| Sub-Total of Non-Current Liabilities |
17,975,637,074.00 |
| Total Liabilities |
33,898,015,757.00 |
| Paid-In Capital(Or Share Stock) |
2,096,599,855.00 |
| Capital Surplus |
1,975,889,177.00 |
| Surplus Reserve |
1,111,880,257.00 |
| LESS:Treasury Stock |
610,051,971.00 |
| Undistributed Profits |
23,257,579,627.00 |
| Minority Stockholder's Interest |
3,345,736,189.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
27,497,871,045.00 |
| Owner's Equity（Stockholder's Equity） |
30,843,607,234.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
64,741,622,991.00 |
